A detailed history of Teacher Retirement System Of Texas transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 16,089 shares of XENE stock, worth $662,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,089
Previous 14,078 14.28%
Holding current value
$662,062
Previous $549,000 15.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.12 - $43.96 $72,637 - $88,403
2,011 Added 14.28%
16,089 $633,000
Q2 2024

Aug 09, 2024

BUY
$36.25 - $43.75 $3,661 - $4,418
101 Added 0.72%
14,078 $549,000
Q1 2024

May 06, 2024

SELL
$42.66 - $50.04 $469 - $550
-11 Reduced 0.08%
13,977 $602,000
Q4 2023

Feb 07, 2024

SELL
$28.7 - $46.46 $12,341 - $19,977
-430 Reduced 2.98%
13,988 $644,000
Q3 2023

Oct 31, 2023

BUY
$34.16 - $39.73 $25,483 - $29,638
746 Added 5.46%
14,418 $493,000
Q2 2023

Jul 19, 2023

SELL
$34.84 - $43.54 $27,140 - $33,917
-779 Reduced 5.39%
13,672 $526,000
Q1 2023

May 12, 2023

BUY
$33.46 - $40.35 $11,108 - $13,396
332 Added 2.35%
14,451 $517,000
Q4 2022

Feb 10, 2023

SELL
$33.06 - $39.43 $27,605 - $32,924
-835 Reduced 5.58%
14,119 $557,000
Q3 2022

Nov 03, 2022

BUY
$30.79 - $39.82 $460,433 - $595,468
14,954 New
14,954 $540,000
Q2 2022

Aug 09, 2022

SELL
$25.44 - $35.16 $217,384 - $300,442
-8,545 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$25.09 - $33.13 $714,638 - $943,641
-28,483 Reduced 76.92%
8,545 $261,000
Q4 2021

Feb 10, 2022

BUY
$15.6 - $35.4 $577,636 - $1.31 Million
37,028 New
37,028 $1.16 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.56B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.